217 related articles for article (PubMed ID: 6222283)
1. Defective monocyte chemotaxis in children with Down's syndrome.
Barroeta O; Nungaray L; López-Osuna M; Armendares S; Salamanca F; Kretschmer RR
Pediatr Res; 1983 Apr; 17(4):292-5. PubMed ID: 6222283
[TBL] [Abstract][Full Text] [Related]
2. Islet autoimmunity in children with Down's syndrome.
Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
[TBL] [Abstract][Full Text] [Related]
3. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
Bartelik S
Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
[TBL] [Abstract][Full Text] [Related]
4. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
[TBL] [Abstract][Full Text] [Related]
6. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction.
Izumi Y; Sugiyama S; Shinozuka O; Yamazaki T; Ohyama T; Ishikawa I
J Periodontol; 1989 May; 60(5):238-42. PubMed ID: 2525619
[TBL] [Abstract][Full Text] [Related]
7. Abnormal serum immunoglobulin levels in Down's syndrome patients.
Nishida Y; Sano Y; Akaoka I; Maruki M; Suzuki T; Maruki K
Am J Ment Defic; 1978 Jul; 83(1):16-20. PubMed ID: 150229
[TBL] [Abstract][Full Text] [Related]
8. Zinc and copper in plasma and erythrocytes of Down's syndrome children.
Purice M; Maximilian C; Dumitriu I; Ioan D
Endocrinologie; 1988; 26(2):113-7. PubMed ID: 2970667
[TBL] [Abstract][Full Text] [Related]
9. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
[TBL] [Abstract][Full Text] [Related]
10. Immunologic parameters in Down's syndrome.
Jacobs PF; Burdash NM; Manos JP; Duncan RC
Ann Clin Lab Sci; 1978; 8(1):17-22. PubMed ID: 146453
[TBL] [Abstract][Full Text] [Related]
11. Chemotaxis in childhood.
Yegin O
Pediatr Res; 1983 Mar; 17(3):183-7. PubMed ID: 6835722
[TBL] [Abstract][Full Text] [Related]
12. Maternal speech to normal and Down's syndrome children matched for mean length of utterance.
Rondal JA
Monogr Am Assoc Ment Defic; 1978; (3):193-265. PubMed ID: 155777
[TBL] [Abstract][Full Text] [Related]
13. Children with Down's syndrome display high rates of hyperuricaemia.
Kashima A; Higashiyama Y; Kubota M; Kawaguchi C; Takahashi Y; Nishikubo T
Acta Paediatr; 2014 Aug; 103(8):e359-64. PubMed ID: 24766390
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the care of children with Down's syndrome with the care of matched controls.
Murdoch JC
J R Coll Gen Pract; 1984 Apr; 34(261):205-9. PubMed ID: 6239032
[TBL] [Abstract][Full Text] [Related]
15. Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing.
Komiyama A; Ichikawa M; Kanda H; Aoyama K; Yasui K; Yamazaki M; Kawai H; Miyagawa Y; Akabane T
Clin Exp Immunol; 1988 Sep; 73(3):500-4. PubMed ID: 3264774
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell function in trisomy-21 (Down's syndrome).
Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
Hann HW; Deacon JC; London WT
Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
[TBL] [Abstract][Full Text] [Related]
18. Distinct abnormalities in the innate immune system of children with Down syndrome.
Bloemers BL; van Bleek GM; Kimpen JL; Bont L
J Pediatr; 2010 May; 156(5):804-9, 809.e1-809.e5. PubMed ID: 20172534
[TBL] [Abstract][Full Text] [Related]
19. Otological disorders in Down's Syndrome.
Satwant S; Subramaniam KN; Prepageran N; Raman R; Jalaludin MA
Med J Malaysia; 2002 Sep; 57(3):278-82. PubMed ID: 12440266
[TBL] [Abstract][Full Text] [Related]
20. T cell response to anti-CD3 antibody in Down's syndrome.
Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
